Rs 95/Sh Dividend: FMCG Stock Gives Update On Dividend, Shares Slip 14.14% From High

Large cap FMCG company Procter & Gamble Hygiene & Health Care Ltd today issued fresh update on payment of Rs 95 per share final dividend. Last trading price of Procter & Gamble Hygiene & Health Care shares on BSE is Rs 16,387.55 per share with decline of 0.92%. Procter & Gamble Hygiene & Health Care shares witnessed decline of 14.14% from 52-week high price of Rs 19,086.26 per share. The FMCG major has a market capitalisation of Rs 53,195.19 crore. Check details below:

Procter & Gamble Hygiene & Health Care Issues Update on Dividend Payment: As per the exchange filing of Procter & Gamble Hygiene dated September 25, 2024, "this has reference to the communication dated August 28,2024, wherein the Board of Directors of the Company at its meeting held on the same day had recommended a final dividend of Rs. 95 per Equity Share (Nominal Value of Rs. 10/- each), for the Financial Year ended June 30, 2024."

We would like to inform you that the divided shall be paid between November 25, 2024 to December 20, 2024, on approval of the Members at the 60th Annual General Meeting, which will be held on November 25,2024, added the exchange filing.

Procter & Gamble Hygiene & Health Shares Performance: The 52-week high price of Procter & Gamble Hygiene & Health SHARES ON bse IS Rs 19,086. 26 per share (as on 20/11/2023) and 52-week low price is Rs 15,306.15 per share (as on 14/03/2024), respectively. Procter & Gamble Hygiene & Health shares slipped over 4% in last 1-month, fell 6% in last 1-year, gained 12% in last 2-years, and jumped 41% in last 5-years.

About: Procter & Gamble Hygiene and Health Care Limited is a leading fast-moving consumer goods (FMCG). The Company is engaged in manufacturing and selling branded packaged FMCG in the feminine care and healthcare businesses. It has two segments: Health care products and Hygiene products.

Disclaimer: The stock highlights the dividend and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither, the author nor Greynium Information Technologies should be held liable for any losses. Please consult a professional advisor.